Christie + Co
HealthInvestor Awards Winners 2014
 
 
Remember me:
Skip Navigation Links
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

31/10/2014
London-listed Cambian has reported continued positive trading for the three months ended 30 September 2014 in its interim management statement.
31/10/2014
Shadow health secretary Andy Burnham has conceded that private providers would still play a role if Labour were to win the general election in May.
30/10/2014
Health secretary Jeremy Hunt has confirmed that the size of the Better Care Fund will be increased to £5.3 billion from the original pledge of £3.8 billion.
28/10/2014
A new programme designed to accelerate the growth of health and social care ventures has launched.
27/10/2014
Priory Group chief executive Tom Riall has said that the company is planning to expand into the community services market.


The Barker Commission demands a closer look at how public sector funding works. But does it make a valid point?
Read more...
Is the Care Quality Commission over-policing the sector, or are the measures a proportionate reaction to a market that needs to get its act together?
Read more...
Monitor has unveiled shocking financial results for the NHS’ second quarter this year. Is the health service finally on the brink?
Private patient units at foundation trusts are not proving a threat to the private sector, yet
Changes are afoot at the Royal College of Nursing and it has potentially serious consequences for private care providers
Candesic’s Dr Joe Taylor argues mHealth is not a luxury, but a necessary element of 21st century medicine for care providers
European Care Group has rebranded as Embrace. Does this mean the future looks brighter for the firm though? Sunniva Davies-Rommetveit meets new CEO Trish Lee

Click here to search all feature articles